Author
Listed:
- Steven Yosiardo Purnama
(Udayana University, Indonesia / Ngoerah General Hospital, Indonesia)
- I. Gde Sastra Winata
(Ngoerah General Hospital, Indonesia)
- I. Nyoman Bayu Mahendra
(Ngoerah General Hospital, Indonesia)
- Ida Bagus Gde Fajar Manuaba
(Ngoerah General Hospital, Indonesia)
- I Gede Ngurah Harry Wijaya Surya
(Ngoerah General Hospital, Indonesia)
- Kadek Fajar Marta
(Ngoerah General Hospital, Indonesia)
Abstract
Background: Epithelial ovarian cancer (EOC) remains one of the most lethal gynecological malignancies owing to difficulties in its early detection. Although CA-125 and HE-4 are commonly used biomarkers, their limited sensitivity, specificity, availability, and cost restrict their clinical application. Inflammatory markers such as C-reactive protein (CRP) and neutrophil-to-lymphocyte ratio (NLR), which are routinely measured and inexpensive, have been proposed as potential indicators associated with malignancy. However, evidence regarding their relationship to epithelial ovarian cancer, particularly in Indonesia, remains limited. Methods: This observational study used a cross-sectional design. Sixty ovarian cancer patients who met the inclusion and exclusion criteria and were treated at Prof. Dr. I.G.N.G. Ngoerah General Hospital, Denpasar, were included. Data on pre-treatment CRP levels, NLR values, and histopathological findings were obtained from medical records. Associations between CRP, NLR, and epithelial ovarian cancer were analyzed using the chisquare test, while the correlation between CRP and NLR was assessed using Spearman’s correlation test. Statistical significance was set at P
Suggested Citation
Steven Yosiardo Purnama & I. Gde Sastra Winata & I. Nyoman Bayu Mahendra & Ida Bagus Gde Fajar Manuaba & I Gede Ngurah Harry Wijaya Surya & Kadek Fajar Marta, 2026.
"Relationship between High C-Reactive Protein Levels and Neutrophil Lymphocyte Ratio in Epithelial Ovarian Cancer,"
European Journal of Medical and Health Sciences, European Open Science, vol. 8(2), pages 60-64, March.
Handle:
RePEc:epw:ejmed0:v:8:y:2026:i:2:id:70210
DOI: 10.24018/ejmed.2026.8.2.70210
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:epw:ejmed0:v:8:y:2026:i:2:id:70210. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Support (email available below). General contact details of provider: https://eu-opensci.org/index.php/ejmed .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.